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Research
AbstrACt
Objective This systematic review aimed to identify and 
describe the evidence for supplementary oxygen for 
spontaneously breathing trauma patients, and for high 
(0.60–0.90) versus low (0.30–0.50) inspiratory oxygen 
fraction (FiO
2) for intubated trauma patients in the initial 
phase of treatment.
Methods Several databases were systematically searched 
in September 2017 for studies fulfilling the following 
criteria: trauma patients (Population); supplementary 
oxygen/high FiO
2 (Intervention) versus no supplementary 
oxygen/low FiO2 (Control) for spontaneously breathing or 
intubated trauma patients, respectively, in the initial phase 
of treatment; mortality, complications, days on mechanical 
ventilation and/or length of stay (LOS) in hospital/intensive 
care unit (ICU) (Outcomes); prospective interventional trials 
(Study design). Two independent reviewers screened and 
identified studies and extracted data from included studies.
results 6142 citations were screened with an inter-rater 
reliability (Cohen’s kappa) of 0.88. One interventional 
trial of intubated trauma patients was included. 68 
trauma patients were randomised to receive an FiO
2 of 
0.80 (intervention group) or 0.50 (control group) during 
mechanical ventilation (first 6 hours). There was no 
significant difference in hospital or ICU LOS between 
the groups. No patient died in either group. Another 
interventional trial, not strictly fulfilling the inclusion 
criteria, was presented for descriptive purposes. 21 
trauma patients were alternately assigned to two types of 
mechanical ventilation (first 48 hours), both aiming at an 
FiO
2 of 0.40, but resulted in estimated mean FiO2s of 0.45 
(intervention group) and 0.60 (control group). No difference 
in days on mechanical ventilation was found. Two patients 
in the control group died, none in the intervention group. 
No prospective, interventional trials on spontaneously 
breathing trauma patients were identified.
Conclusions Evidence for the use of supplementary 
oxygen for spontaneously breathing trauma patients is 
lacking, and the evidence for low versus high FiO
2 for 
intubated trauma patients is limited.
PrOsPErO registration number 42016050552
bACkgrOund 
Trauma is estimated to be the number one 
cause of death for persons between 1 and 44 
years of age,1 and costs related to trauma are 
a significant economic burden to society.2 
The initial (prehospital and early in-hos-
pital) treatment of trauma patients can be 
crucial for the subsequent injury outcome, 
but current management is based on guide-
lines that are not generally well supported by 
evidence,1 3 as research in this setting is diffi-
cult to conduct for numerous reasons.
Oxygen is probably the most commonly 
administered drug both in the prehospital 
and emergency department setting, and 
several studies have found supplementary 
oxygen to be widely used in the prehospital 
treatment of trauma patients.4–6 Oxygen is 
cheap, easily administered and, at least for 
shorter time frames, widely believed to be 
without any risk of harm. Supplementary 
oxygen treatment is recommended interna-
tionally in both the Advanced Trauma Life 
Support (ATLS) manual and the PreHospital 
Trauma Life Support manual.1 3 This often 
leads to a ‘default’ administration of oxygen 
even without an indication.5 Supplementary 
oxygen treatment is provided to prevent 
or correct hypoxaemia, as this may cause 
tissue hypoxia with organ injury. However, 
supplementary oxygen introduces a risk of 
hyperoxaemia which is associated with a risk 
of complications, especially lung damage, 
and liberal use of oxygen is associated with 
greater morbidity and mortality in surgical 
patients and in patients with acute conditions 
like stroke, myocardial infarction and cardiac 
arrest (CA).7–10
strengths and limitations of this study
 ► The use of predefined Population, Intervention, 
Control, Outcomes, Study design criteria to assess 
for study eligibility.
 ► The use of a wide search string in multiple databases.
 ► The use of a structured screening and inclusion 
process, as well as data collection and risk of bias 
assessment by two independent authors.
 ► There is a possibility of missing unpublished studies 
which creates a potential publication bias.
 ► It is possible that we did not identify all relevant 
studies despite our systematic methodology.
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In intubated patients, an inspiratory oxygen fraction 
(FiO2) of 0.30–0.50 is often used during mechanical venti-
lation. A high FiO2 (0.60–0.90) intraoperatively has been 
suggested to reduce the incidence of surgical site infec-
tion; however, a recent systematic review did not detect a 
beneficial effect.10–12
As the evidence behind the current trauma guidelines 
with regard to oxygen therapy is not clear, and excessive 
oxygen administration has been found to be harmful in 
other patient populations, we sought to perform a system-
atic review to identify and summarise the evidence for the 
use of supplementary oxygen for spontaneously breathing 
trauma patients, and the use of high (0.60–0.90) versus 
low (0.30–0.50) FiO2 for intubated trauma patients.
MEthOds
Protocol and registration
We conducted a systematic review following the recom-
mendations by the Cochrane Collaboration13 and the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) Statement.14 The protocol was 
completed following the PRISMA Protocols15 and was 
registered in the International Prospective Register of 
Systematic Reviews.16
Eligibility criteria
Inclusion of studies was based on the following predefined 
Population, Intervention, Control, Outcomes, Study 
design (PICOS) criteria: trauma patients >17 years of 
age (Population); supplementary oxygen (Intervention) 
versus no supplementary oxygen (Control) for sponta-
neously breathing trauma patients and/or high (0.60–
0.90) (Intervention) versus low (0.30–0.50) (Control) 
FiO2 for intubated trauma patients in the initial phase 
of treatment (<24 hours after the traumatic incident 
including both prehospital and in-hospital phases); 
all-cause mortality, in-hospital mortality, in-hospital 
complications, days on mechanical ventilation and/
or length of stay (LOS) in hospital/intensive care unit 
(ICU) (Outcomes); prospective interventional trials 
(randomised and non-randomised) (Study design). 
Observational studies, reviews, expert opinions, case 
reports, letters, abstracts and editorials were excluded. 
There was no restriction to language or year of publica-
tion. Potential eligible studies where the full text could 
not be found were excluded.
Information sources and search methods
We searched MEDLINE, EMBASE and the Cochrane 
Library from inception to 22 September 2016 using the 
following predefined search string (presented search 
strategy is from MEDLINE):
1. ((trauma) OR traumat*) OR traumatic injury
2. (((((oxygen*) OR oxygen) OR oxygenation) OR sup-
plemental oxygen) OR fio2) OR hyperox*
3. ((((((((30 day mortality) OR mortal*) OR all cause 
mortality) OR complicat*) OR in-hospital mortality) 
OR length of stay) OR LOS) OR hospital mortali-
ty[MeSH Terms]) OR mortality[MeSH Terms]
4. #1 AND #2 AND #3
5. Filter: Humans
Modification of the search string was made to fit 
EMBASE and the Cochrane Library format, respectively. 
The search was updated on 3 September 2017, and no 
new studies were found.
study selection
Two independent authors (TGE and JSB) screened titles 
and abstracts from the primary search in all three data-
bases. Screening was performed using Covidence (an 
online program facilitating the production of systematic 
reviews developed by the Cochrane Group).17 Inter-rater 
reliability was calculated using Cohen’s kappa statistics. 
Both authors evaluated relevant studies in full text inde-
pendently. Disagreement was resolved by discussion. If 
agreement could not be reached, a senior author (JS or 
LSR) was involved. Bibliographies of included studies 
were reviewed for further potentially relevant studies 
(so-called ‘snowballing’).
data collection and data items
Data extraction was performed by two authors (TGE, JSB) 
independently using predetermined forms and facilitated 
by the data-extraction tool in Covidence. Collected study 
characteristics included study setting and country, study 
period and publication year. Data on methods, popula-
tion, interventions and outcomes included study design, 
blinding, aim of the study, inclusion and exclusion 
criteria, number of included patients, baseline character-
istics (ie, age, gender, mechanism of injury), fraction of 
inspired oxygen and oxygenation assessment of the inter-
vention and control group, respectively, as well as any of 
the predefined outcome measures (primary outcome 
measure: all-cause mortality at 30 days; secondary outcome 
measures: in-hospital mortality, in-hospital complications, 
days on mechanical ventilation and/or LOS in hospital/
ICU).
risk of bias assessment
The quality of the included studies was assessed by two 
independent authors (TGE, JSB) using the Cochrane risk 
of bias assessment tool in Covidence18 which consists of 
seven specific domains (random sequence generation, 
allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete 
outcome data, selective reporting and other bias). In 
each domain, the study is judged to have a low, high or 
unclear risk of bias.
summary measures and synthesis of results
This systematic review was expected to be a descriptive 
summary of the current evidence.
Patient and public involvement
There was no patient involvement in this study.
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rEsults
Our combined search strategy identified 6142 records 
to be considered for inclusion. After screening titles and 
abstracts, 60 articles were evaluated in full text for eligi-
bility. An inter-rater reliability (Cohen’s kappa) of 0.88 
(CI: 0.82 to 0.94) for screening and selecting studies was 
obtained. After full-text review, only one study fulfilled 
the inclusion criteria and was included in the systematic 
review19 (figure 1). Another study, which did not strictly 
fulfil the inclusion criteria, was also included for descrip-
tive purposes. Both studies were prospective, interven-
tional trials and included intubated trauma patients, and 
thus no prospective, interventional trials of spontaneously 
breathing trauma patients were identified. Characteris-
tics, methods and results for the two included studies are 
summarised in table 1.
Taher et al19 performed a randomised study of 68 
mechanically ventilated adult patients sustaining 
severe traumatic brain injury (TBI). The patients were 
randomised to receive an FiO2 of either 0.80 (inter-
vention group) or 0.50 (control group) during the 
first 6 hours of treatment. A total of 34 patients in each 
group completed the study. The two groups were similar 
in terms of age, gender distribution and GCS on admis-
sion. Relevant outcomes for this systematic review were 
LOS in hospital and LOS in ICU. The study found no 
statistically significant difference between the inter-
vention and control groups in either of these outcome 
measures (hospital LOS: 11.4 days (SD: 5.4) vs 13.9 days 
(SD: 8.1), respectively, p=0.14; ICU LOS: 9.4 days (SD: 
6.6) vs 11.4 days (SD: 8.4), respectively, p=0.28). No 
patients in either group died.
The study by Barzilay et al20 included 21 adult patients 
with chest trauma and severe respiratory insufficiency 
due to flail chest or pulmonary contusion requiring 
mechanical ventilation. Patients were alternately 
assigned to two different mechanical ventilation strat-
egies: conventional mechanical ventilation or high-fre-
quency positive pressure with low-rate ventilation. FiO2 
was set to be 0.40 in both groups, but subsequently 
adjusted to arterial oxygen tension (PaO2) and there-
fore different between the two groups according to 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of the identification, screening, 
eligibility and inclusion process.14 *One of the included studies20 did not strictly meet the inclusion criteria; however, it is 
included for descriptive purposes.
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the results. Eleven patients in the intervention group 
received an estimated mean FiO2 of 0.45 and had a mean 
PaO2 of 89.91±10.24 mm Hg during the first 48 hours 
after hospital admission. The control group consisted 
of 10 similar patients receiving an estimated mean FiO2 
of 0.60 and had a mean PaO2 of 78.43±11.13 mm Hg 
during the first 48 hours after hospital admission. 
Neither of these FiO2s were reported in detail, but can 
be estimated from the data provided in the article. No 
simple relationship was found between the estimated 
FiO2 and PaO2 values presumably as a consequence of 
the two different ventilation strategies. Outcomes rele-
vant to this systematic review were days on mechanical 
ventilation and mortality. The study found no statisti-
cally significant difference in days on mechanical venti-
lation between the intervention group and the control 
Table 1 Characteristics, methods and results for the included studies of supplementary oxygen for trauma patients
Taher et al19 Barzilay et al20*
Study characteristics
  Setting Emergency ward General ICU
  Period 2014 January 1981–January 1984
  Geographical location Hamadan, Iran Afula, Israel
Methods
  Aim ‘…to assess the effects of normobaric hyperoxia on 
clinical neurological outcomes of patients with severe 
TBIs.’
‘…compare the results using ventilatory 
method, which combines HFPPV [high-
frequency positive-pressure ventilation] 
and low-rate conventional mechanical 
ventilation (LRCMV), to the results using 
conventional mechanical ventilation 
(CMV) with PEEP.’
  Blinding Double blinded. Not reported.
  Study design Randomised controlled trial. Interventional, non-randomised.
  Inclusion criteria Age 18–65 years; <6 hours passed since the accident; 
haemodynamic stability; GCS 3–8.
All patients admitted to the ICU with 
a diagnosis of severe respiratory 
insufficiency due to flail chest or 
pulmonary contusion.
  Exclusion criteria Pregnancy; chronic disease such as diabetes mellitus, 
ischaemic heart disease, renal failure, acute pulmonary 
oedema, history of massive myocardial infarction and 
heart failure; blood pressure <90/60 mm Hg; successful 
CPR; death or loss to follow-up; patients in the control 
group in which oxygen therapy was inevitable.
Not reported.
Intervention group Control group Intervention group Control group
Results
  No of patients 34 34 11 10
  Age (years), mean (SD) 39.7 (14.1) 45.7 (13.3) 40.6 (22.45) 39.8 (18.18)
  Female sex, n (%) 9 (26.5) 11 (32.4) Not reported Not reported
  GCS on admission, mean (SD) 7.4 (0.79) 7.4 (0.89)
  FiO2, mean (SD) 0.80 0.50 0.45† 0.60†
  PaO2(mm Hg), mean (SD) Not reported Not reported 89.91±10.24† 78.43±11.13†
  Outcome measures
  30-Day all-cause mortality, n (%) 0 (0) 0 (0) 0 (0) 2 (20)
  Hospital LOS (days) 11.4 (5.4) 13.9 (8.1) Not reported Not reported
  ICU LOS (days) 9.4 (6.6) 11.4 (8.4) Not reported Not reported
  Days on mechanical ventilation, 
mean (SD)
Not reported Not reported 4.2 (0.91) 6.1 (0.8)
*This study did not strictly meet the inclusion criteria; however, it was included for descriptive purposes.
†During the first 48 hours in hospital (FiO2 estimated from other results).
CPR, cardiopulmonary resuscitation; FiO2, inspiratory oxygen fraction; GCS, Glasgow Coma Scale Score; ICU, intensive care unit; LOS, 
length of stay; PaO2, arterial oxygen tension; PEEP, positive end expiratory pressure; TBI, traumatic brain injury.
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group (4.2 days (SD: 0.91) vs 6.1 days (SD: 0.8), respec-
tively, p<0.1). In terms of mortality, two (20%) patients 
in the control group died compared with none in the 
intervention group. The p value was not reported, but 
the difference was not statistically significant using Fish-
er’s exact test.
The risk of bias assessment for the included studies is 
presented in table 2. In the study by Taher et al, three 
domains were judged to have a low risk of bias (blinding 
of participants and personnel, blinding of outcome 
assessment, incomplete outcome data), none to have a 
high risk of bias, and four domains to have an unclear 
risk of bias (random sequence generation, allocation 
concealment, selective reporting, other bias). The study 
by Barzilay et al was judged to have two domains with 
low risk of bias (blinding of participants and personnel, 
blinding of outcome assessment), two domains with 
high risk of bias (allocation concealment, other bias) 
and three domains with an unclear risk of bias (random 
sequence generation, incomplete outcome data, selec-
tive reporting).
dIsCussIOn
summary of evidence
In this systematic review of interventional trials of the 
use of supplementary oxygen in the initial treatment 
of trauma patients, we identified no studies of sponta-
neously breathing patients, and only one interventional 
trial of intubated trauma patients was found to fulfil the 
inclusion criteria. Taher et al19 found the low FiO2 group 
(0.50) to have slightly longer LOS in hospital and LOS 
in ICU than the high-FiO2 group (0.80); however, these 
differences were not statistically significant. Addition-
ally, no patient died in either group. In another study by 
Barzilay et al,20 which did not strictly fulfil the inclusion 
criteria, no statistically significant differences were found 
between the groups, although patients in the high-FiO2 
group (0.60) tended to have a higher mortality and 
more days on mechanical ventilation than the patients in 
the low-FiO2 group (0.45). Due to the low number and 
heterogeneity of the included studies, we neither found it 
possible to pool the results of the two studies, nor to draw 
any conclusions from these findings.
Table 2 Risk of bias assessment for the two included studies
Risk of bias domain
Taher et al19 Barzilay et al20*
Judgement Support for judgement Judgement Support for judgement
Random sequence 
generation (selection 
bias)
Unclear Quote: ‘…patients were divided 
in two groups…’.
Comment: Not a random 
component in the sequence 
generation process.
Unclear Comment: No description of a random 
component in the sequence generation 
process.
Allocation concealment 
(selection bias)
Unclear Comment: No description of 
allocation concealment.
High Quote: ‘Patients were assigned 
alternately to two groups’.
Comment: Investigators had the 
possibility of foreseeing the assignment.
Blinding of participants 
and personnel 
(performance bias)
Low Quote: ‘In this double blind 
clinical trial…’.
Comment: Probably done.
Low Comment: No blinding is described, but 
the relevant outcomes are not likely to 
be influenced by lack of blinding.
Blinding of outcome 
assessment (detection 
bias)
Low Comment: No blinding of 
outcome assessment is 
described, but the relevant 
outcomes are not likely to be 
influenced by lack of blinding.
Low Comment: No blinding of outcome 
assessment is described, but the 
relevant outcomes are not likely to be 
influenced by lack of blinding.
Incomplete outcome 
data (attrition bias)
Low Comment: Outcome is reported 
for all included patients.
Unclear Comment: The outcomes are not 
described as being defined before 
commencing the study.
Selective reporting 
(reporting bias)
Unclear Comment: No protocol is 
available and the reported 
outcomes are not prespecified in 
the methods section.
Unclear Comment: As outcomes are not 
described as being defined before 
commencing the study, there is 
insufficient information to assess this 
domain.
Other bias Unclear Comment: There is insufficient 
information on the study design 
to assess whether an important 
risk of bias exists.
High Quote: ‘Those in the study group were 
connected to a two-ventilator HFPPV 
system of our own design’.
Comment: The authors are likely to have 
a preference for their own design.
*This study did not strictly meet the inclusion criteria, however, it was included for descriptive purposes.
HFPPV, high-frequency positive-pressure ventilation. 
 o
n
 6 M
arch 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020880 on 6 July 2018. Downloaded from 
6 Eskesen TG, et al. BMJ Open 2018;8:e020880. doi:10.1136/bmjopen-2017-020880
Open access 
The rationale for supplementation of oxygen for 
various patient groups has for decades—and even centu-
ries—seemed self-evident for most healthcare providers.21 
Oxygen supplementation, often in excess, has been consid-
ered a safe measure rather than an intervention that could 
potentially be harmful and thus needing a clear indication 
of administration. Supplementation of oxygen has, until 
recently, escaped the critical evaluation of its value and indi-
cation as is necessary for all other drugs not having the same 
historical, ‘self-evident’ benefit as is the case for oxygen. As 
previously described, trauma patient management is mostly 
based on guideline recommendations including rather 
liberal and non-specific oxygen supplementation. Thus, it 
seems surprising that, even though supplementary oxygen 
is widely used in the treatment of trauma patients and 
included in international trauma guidelines, this systematic 
review finds that the evidence for the use of supplemen-
tary oxygen for spontaneously breathing trauma patients 
is non-existing, and for mechanically ventilated trauma 
patients the evidence is extremely limited and of low quality. 
In an era of evidence-based medicine these findings seem 
inappropriate, and we cannot continue to avoid investi-
gating the potential benefits and harms of a drug that is so 
widely used.
Supplementary oxygen increases the PaO2 of oxygen in 
the alveoli, thus increasing the oxygen gradient across the 
alveolar–capillary membrane. This is likely to increase the 
PaO2 when oxygenation is impeded by a barrier in the trans-
port of oxygen across the alveolar–capillary membrane. 
However, that is not common in trauma patients. On the 
other hand, it can be reasonable to administer supplemen-
tary oxygen in order to increase the amount of oxygen in 
the lungs to prolong the safe apnoea time.22
Both hypoxaemia and hyperoxaemia may be harmful. 
Hypoxaemia may cause hypoxic neuronal cell death leading 
to irreversible brain damage, whereas hyperoxaemia has 
been found to increase the risk of pulmonary complications 
like the formation of atelectases and airway inflammation.23
The effect of hyperoxia on outcomes following TBI has 
been investigated in a few retrospective studies. Rincon 
et al24 and Brenner et al25 assessed short-term outcomes 
and they both found hyperoxia to be associated with 
increased in-hospital mortality compared with normoxia. 
Additionally, Brenner et al found that hyperoxia was asso-
ciated with lower GCS scores at discharge. Another retro-
spective study by Davis et al26 of patients with moderate 
to severe TBI found both hypoxaemia and hyperoxaemia 
to be correlated with decreased survival to discharge 
compared with patients with normoxia. In contrast, Raj 
et al27 detected no association between hyperoxaemia and 
6-month mortality.
The evidence for the use of supplementary oxygen has 
been investigated in recently published systematic reviews. 
In a Cochrane review from 2015, Wetterslev et al10 included 
28 studies and found no association between perioper-
ative FiO2 (high: 0.60–0.90 vs low: 0.30–0.40) and post-
operative surgical site infection and mortality. In another 
Cochrane review of supplementary oxygen for patients 
with suspected or confirmed acute myocardial infarc-
tion (AMI), Cabello et al28 included five studies, and they 
were not able to draw conclusions for or against the use 
of supplementary oxygen for patients with AMI. Hyper-
oxia in postreturn of spontaneous circulation CA patients 
has been studied in a systematic review and meta-analysis 
by Wang et al.9 Fourteen studies were included, and the 
authors found hyperoxia to be correlated with increased 
in-hospital mortality in a meta-analysis of eight of the 
included studies. Finally, Damiani et al7 have looked at 
the association between arterial hyperoxia and mortality 
for adult ICU patients (mechanically ventilated, post-CA, 
stroke, TBI) in a systematic review and meta-analysis from 
2014 of 17 studies. In the meta-analysis, hyperoxia was 
associated with increased mortality for patients post-CA, 
stroke and TBI, though the authors report the studies to be 
rather heterogeneous. As the trauma population is a very 
heterogeneous and typically a younger and less comorbid 
group of patients than other critically ill populations (ie, 
AMI, CA, stroke), the results of the before-mentioned 
systematic reviews of other patient populations cannot be 
extrapolated to the trauma population. However, there 
seems to be an implication that treatment with excess 
oxygen and hyperoxia can be harmful or at least not 
beneficial. This, again, stresses the need for investigating 
the effects of supplementary oxygen and cases of hyper-
oxia in the trauma population.
strengths and limitations
This systematic review was conducted in accordance with 
the PRISMA guidelines14 ensuring a systematic and interna-
tionally accepted methodological approach. The strengths 
of this approach include predefined PICOS criteria used 
to assess for study eligibility, the use of a wide search string 
in multiple databases, a structured screening and inclusion 
process by two independent authors, and data collection 
and risk of bias assessment by the same two independent 
authors using predetermined forms. Our study is limited 
by the weaknesses of a systematic review in general: the 
possibility of missing unpublished studies which creates a 
potential publication bias, and the possibility that we did not 
identify all relevant studies despite our systematic method-
ology. The patient population we included was defined in 
rather general terms (ie, adult trauma patients) which may 
have increased the heterogeneity of the studies; however, 
we found this to be necessary in order to increase the clin-
ical relevance of our findings. We wanted to study the initial 
treatment phase of trauma patients and chose this to be the 
first 24 hours after the traumatic incident. This time cut-off 
was chosen rather arbitrarily and did exclude one poten-
tially eligible study.29 As per our inclusion criteria for this 
systematic review, we wanted to include both prehospital 
and in-hospital studies; however, both included studies 
investigated in-hospital patients with no data on the prehos-
pital supplementary oxygen treatment. As a large propor-
tion of trauma patients receive prehospital supplementary 
oxygen,5 6 it is a limitation not to know whether the per 
protocol FiO2-group allocation is the only oxygenation 
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treatment the patient has received since the traumatic 
incident.
The study by Barzilay et al was included in the review 
despite lacking strict adherence to the inclusion criteria. 
We chose to do this, as evidence in this field proved to be 
extremely sparse, and we wished to report as much of the 
existing evidence as possible.
We were only able to include two small studies of 
mechanically ventilated trauma patients, and two 
different methods of mechanical ventilation were used 
in the study by Barzilay et al. Thus, the studies were not 
suitable for pooling results, and we were neither able 
to draw any conclusions nor provide recommendations 
for the FiO2 for mechanically ventilated trauma patients. 
Furthermore, as no studies of spontaneously breathing 
trauma patients were found, we cannot provide recom-
mendations for the use of supplementary oxygen for 
spontaneously breathing trauma patients either.
COnClusIOns
In this systematic review of supplementary oxygen for trauma 
patients in the initial phase of treatment, we identified no 
interventional trials including spontaneously breathing 
trauma patients and only two small low-quality studies 
assessing oxygen fraction in intubated trauma patients. 
Thus, the current practice of liberal oxygen administration 
must be questioned, and interventional studies of supple-
mentary oxygen should be conducted in trauma patients.
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